Community Pharmacy-Based eGFR Screening for Early Detection of CKD in High Risk Patients
Background: Chronic kidney disease (CKD) is a condition presenting with long-term slow progression of structural and/or functional damage to the kidneys. Early detection is key to preventing complications and improving outcomes. Point-of-care estimated glomerular filtration rate (eGFR) screening tec...
Main Authors: | John Papastergiou, Michelle Donnelly, Wilson Li, Robert D. Sindelar, Bart van den Bemt |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-05-01
|
Series: | Canadian Journal of Kidney Health and Disease |
Online Access: | https://doi.org/10.1177/2054358120922617 |
Similar Items
-
Pharmacogenetic-guided cannabis usage in the community pharmacy: evaluation of a pilot program
by: John Papastergiou, et al.
Published: (2020-09-01) -
Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRD.
by: Carsten A Böger, et al.
Published: (2011-09-01) -
POS-435 CHANGE IN eGFR BY CKD STAGE IN PRIMARY HYPEROXALURIA TYPE 1
by: P. SINGH, et al.
Published: (2021-04-01) -
Normality data of eGFR and validity of commonly used screening tests for CKD in an area with endemic CKD of unknown etiology; need for age and sex based precise cutoff values
by: Nalaka Herath, et al.
Published: (2019-08-01) -
Community pharmacist-led point-of-care eGFR screening: early detection of chronic kidney disease in high-risk patients
by: Ammar Abdulrahman Jairoun, et al.
Published: (2024-03-01)